The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome

Hormones and Behavior

Volumn 59, Issue 4, 2011, Pages 444-450

  Van Nieuwpoort, I C ^a   Deijen, J B ^b   Curfs, L M G ^c   Drent, M L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cognition; IGF I; IQ; PWS; QoL

Indexed keywords

SOMATOMEDIN C;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REACTION TIME; SCORING SYSTEM;

ADULT; COGNITION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTELLIGENCE; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PRADER-WILLI SYNDROME; QUALITY OF LIFE; REACTION TIME;

EID: 79954678387     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.01.001     Document Type: Article

References (50)

1. Adem A., Jossan S.S., d'Argy R., Gillberg P.G., Nordberg A., Winblad B., Sara V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res. 1989, 503:299-303.
2. Arwert L.I., Deijen J.B., Drent M.L. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm. IGF Res. 2005, 15:416-422.
3. Bertella L., Mori I., Grugni G., Pignatti R., Ceriani F., Molinari E., Ceccarelli A., Sartorio A., Vettor R., Semenza C. Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J. Intellect. Disabil. Res. 2007, 51:302-311.
4. Brambilla P., Bosio L., Manzoni P., Pietrobelli A., Beccaria L., Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am. J. Clin. Nutr. 1997, 65:1369-1374.
5. Buiting K., Saitoh S., Gross S., Dittrich B., Schwartz S., Nicholls R.D., Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 1995, 9:395-400.
6. Burman P., Ritzen E.M., Lindgren A.C. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr. Rev. 2001, 22:787-799.
7. Caliandro P., Grugni G., Padua L., Kodra Y., Tonali P., Gargantini L., Ragusa L., Crino A., Taruscio D. Quality of life assessment in a sample of patients affected by Prader-Willi syndrome. J. Paediatr. Child Health 2007, 43:826-830.
8. Cassidy S.B. Prader-Willi syndrome. J. Med. Genet. 1997, 34:917-923.
9. Cassidy S.B., Driscoll D.J. Prader-Willi syndrome. Eur. J. Hum. Genet. 2009, 17:3-13.
10. Cherrier M.M., Plymate S., Mohan S., Asthana S., Matsumoto A.M., Bremner W., Peskind E., Raskind M., Latendresse S., Haley A.P., Craft S. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology 2004, 29:65-82.
11. Copet P., Jauregi J., Laurier V., Ehlinger V., Arnaud C., Cobo A.M., Molinas C., Tauber M., Thuilleaux D. Cognitive profile in a large French cohort of adults with Prader-Willi syndrome: differences between genotypes. J. Intellect. Disabil. Res. 2010, 54:204-215.
12. Corrias A., Bellone J., Beccaria L., Bosio L., Trifiro G., Livieri C., Ragusa L., Salvatoni A., Andreo M., Ciampalini P., Tonini G., Crino A. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. J. Endocrinol. Investig. 2000, 23:84-89.
13. Curfs L.M., Wiegers A.M., Sommers J.R., Borghgraef M., Fryns J.P. Strengths and weaknesses in the cognitive profile of youngsters with Prader-Willi syndrome. Clin. Genet. 1991, 40:430-434.
14. Davies P.S. Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration. Acta Paediatr. Suppl. 1999, 88:105-108.
15. Deijen J.B., Arwert L.I. Impaired quality of life in hypopituitary adults with growth hormone deficiency: can somatropin replacement therapy help?. Treat. Endocrinol. 2006, 5:243-250.
16. Dykens E.M., Hodapp R.M., Walsh K., Nash L.J. Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. J. Am. Acad. Child Adolesc. Psychiatry 1992, 31:1125-1130.
17. Gabel S., Tarter R.E., Gavaler J., Golden W.L., Hegedus A.M., Maier B. Neuropsychological capacity of Prader-Willi children: general and specific aspects of impairment. Appl. Res. Ment. Retard. 1986, 7:459-466.
18. Goldstone A.P., Thomas E.L., Brynes A.E., Bell J.D., Frost G., Saeed N., Hajnal J.V., Howard J.K., Holland A., Bloom S.R. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J. Clin. Endocrinol. Metab. 2001, 86:4330-4338.
19. Goldstone A.P., Brynes A.E., Thomas E.L., Bell J.D., Frost G., Holland A., Ghatei M.A., Bloom S.R. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am. J. Clin. Nutr. 2002, 75:468-475.
20. Goldstone A.P., Holland A.J., Hauffa B.P., Hokken-Koelega A.C., Tauber M. Recommendations for the diagnosis and management of Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2008, 93:4183-4197.
21. Gross-Tsur V., Landau Y.E., Benarroch F., Wertman-Elad R., Shalev R.S. Cognition, attention, and behavior in Prader-Willi syndrome. J. Child Neurol. 2001, 16:288-290.
22. Grugni G., Marzullo P., Ragusa L., Sartorio A., Trifiro G., Liuzzi A., Crino A. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. Clin. Endocrinol. (Oxf) 2006, 65:492-499.
23. Hashimoto T., Mori K., Yoneda Y., Yamaue T., Miyazaki M., Harada M., Miyoshi H., Kuroda Y. Proton magnetic resonance spectroscopy of the brain in patients with Prader-Willi syndrome. Pediatr. Neurol. 1998, 18:30-35.
24. Hill A.J., Rogers P.J., Blundell J.E. Techniques for the experimental measurement of human eating behaviour and food intake: a practical guide. Int. J. Obes. Relat. Metab. Disord. 1995, 19:361-375.
25. Holm V.A., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Whitman B.Y., Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91:398-402.
26. Hoybye C. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm. IGF Res. 2004, 14:1-15.
27. Hoybye C., Thoren M., Bohm B. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. J. Intellect. Disabil. Res. 2005, 49:245-252.
28. Huisman J., Aukema E.J., Deijen J.B., van Coeverden S.C., Kaspers G.J., van der Pal H.J., Delemarre-van de Waal H.A. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study. BMC Pediatr. 2008, 8:25.
29. Hunt S.M., McEwen J., McKenna S.P. Measuring health status: a new tool for clinicians and epidemiologists. J. R. Coll. Gen. Pract. 1985, 35:185-188.
30. Jauregi J., Arias C., Vegas O., Alen F., Martinez S., Copet P., Thuilleaux D. A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. J. Intellect. Disabil. Res. 2007, 51:350-365.
31. Ledbetter D.H., Riccardi V.M., Airhart S.D., Strobel R.J., Keenan B.S., Crawford J.D. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N. Engl. J. Med. 1981, 304:325-329.
32. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 1985, 41:810-817.
33. Luteijn F., Van der Ploeg F. Handleiding Groninger Intelligentietest (GIT) [Manual Groningen Intelligence Test] 1983, Swets and Zeitlinger, Lisse, The Netherlands.
34. McKenna S.P., Doward L.C., Alonso J., Kohlmann T., Niero M., Prieto L., Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual. Life Res. 1999, 8:373-383.
35. Miller J., Kranzler J., Liu Y., Schmalfuss I., Theriaque D.W., Shuster J.J., Hatfield A., Mueller O.T., Goldstone A.P., Sahoo T., Beaudet A.L., Driscoll D.J. Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J. Pediatr. 2006, 149:192-198.
36. Myers S.E., Whitman B.Y., Carrel A.L., Moerchen V., Bekx M.T., Allen D.B. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am. J. Med. Genet. A 2007, 143:443-448.
37. Nicholls R.D., Knoll J.H., Butler M.G., Karam S., Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 1989, 342:281-285.
38. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 2000, 21:330-348.
39. Olsson G.M., Hulting A.L. Intellectual profile and level of IQ among a clinical group of obese children and adolescents. Eat. Weight Disord. 2010, 15:e68-e73.
40. Owen A.M., Downes J.J., Sahakian B.J., Polkey C.E., Robbins T.W. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 1990, 28:1021-1034.
41. Prader A., Labhart A., Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz. Med. Wochenschr. 1956, 86:1260-1261.
42. Raven J., Raven J.C., Court J.H. Section 1: General overview, manual for Raven's progressive matrices and vocabulary scales. Harcourt Assessment, San Antonio, TX 2003.
43. Roof E., Stone W., MacLean W., Feurer I.D., Thompson T., Butler M.G. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J. Intellect. Disabil. Res. 2000, 44(Pt 1):25-30.
44. Stauder J.E., Boer H., Gerits R.H., Tummers A., Whittington J., Curfs L.M. Differences in behavioural phenotype between parental deletion and maternal uniparental disomy in Prader-Willi syndrome: an ERP study. Clin. Neurophysiol. 2005, 116:1464-1470.
45. van Doorn J., Oltmans H.F., Wit J.M., van Buul-Offers S.C., Jansen M., van den Brande J.L. Clinical relevance of the measurement of insulin-like growth factors in plasma. Ned. Tijdschr. Geneeskd 1991, 135:1730-1735.
46. van Nieuwpoort I.C., Drent M.L. Cognition in the adult with childhood-onset GH deficiency. Eur. J. Endocrinol. 2008, 159(Suppl 1):S53-S57.
47. Waters J., Clarke D.J., Corbett J.A. Educational and occupational outcome in Prader-Willi syndrome. Child Care Health Dev. 1990, 16:271-282.
48. Whittington J., Holland A., Webb T., Butler J., Clarke D., Boer H. Academic underachievement by people with Prader-Willi syndrome. J. Intellect. Disabil. Res. 2004, 48:188-200.
49. Whittington J., Holland A., Webb T., Butler J., Clarke D., Boer H. Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J. Intellect. Disabil. Res. 2004, 48:172-187.
50. Whittington J., Holland A., Webb T. Relationship between the IQ of people with Prader-Willi syndrome and that of their siblings: evidence for imprinted gene effects. J. Intellect. Disabil. Res. 2009, 53(5):411-418.